Pharmacists Poised to Play Larger Role in Uptake of Biosimilars
With the backing of new laws, retail pharmacists have considerable freedom to switch patients to FDA approved interchangeable biosimilars. While most are willing to use that freedom, according to a new report, unanswered questions remain.
New Medication Offers New Hope for Heart Patients
Things are looking up for patients who have an uncommon heart condition. The Food and Drug Administration last month approved a novel medication to treat obstructive hypertrophic cardiomyopathy.
Alzheimer’s Patients Dealt a Devastating Blow
With the finalization of a controversial draft policy, one federal agency dashed the hopes of millions of people living with Alzheimer’s and related dementias.
Innovation Puts Patients Back in Charge
By Robert Fekete, MD – Getting tardive dyskinesia is devastating for mental health patients who are getting back on track.
The Value of Innovation Policy Forum in Five Quotes
What is medical innovation worth? To explore this question, the Institute for Patient Access recently convened health policy and patient advocacy professionals for the Value of Innovation Policy Forum in Washington, D.C.
Innovative Treatments Open Doors for Nurses & Rheumatic Disease Patients
Treating patients with rheumatic diseases often involves using biologic medications, including biosimilars.
When a Small Cry is Worth It
No parent wants to see their child wince in pain or hear their baby cry. Yet enduring the undesirable for just a minute – as the child is vaccinated – can save heartache down the road.
Unlocking Codes for Rare Disease Patients
What stands between rare cancer patients and life-saving treatment? A 3-to-7-character alpha-numeric code.
One-sided Ads Put Patients’ Health at Risk
By Chloe Villavaso, MN, APRN, CNS – When I became an advanced practice nurse, I never thought I’d be competing with the television for my patient’s trust. Yet here I am.
Prescription Digital Therapeutics Blend Technology with Patient-Centered Care
Technology continues to revolutionize how patients and providers tackle complex medical conditions. The latest example? Prescription digital therapeutics.
